Patent details

300631 Product Name: Ponatinib, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout, solvaat of hydraat.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300631
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1973545
Status:
SPC granted but not yet in force
Application number:
300631
Procedural language:
Dutch
First Applicant Residence Country:

Marketing Authorization

Marketing Authorization Number:
EU/1/13/839/001-004
Marketing Authorization Type:
EEA
Marketing Authorization Date:
01/07/2013
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
13/12/2013
First Marketing Authorization date:
01/07/2013
Grant date:
03/06/2014
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
13/12/2013
SPC/SPC Extension Expiration Date:
30/06/2028
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
05/03/2025
 
 

 

Name:
Takeda Pharmaceuticals U.S.A., Inc.
Address:
500 Kendall Street, 02142, Cambridge, MA, United States of America (US)

Historical Applicant/holder

From:
05/03/2025
To:
05/03/2025

 

Name:
ARIAD PHARMACEUTICALS, INC.
Address:
26 Landsdowne Street, 02139, Cambridge, MA, United States of America (US)

From:
13/12/2013
To:
05/03/2025

 

Name:
ARIAD PHARMACEUTICALS, INC.
Address:
26 Landsdowne Street, CAMBRIDGE, MA 02139-4234, United States of America (US)

Agent

Name:
ir. B.Ch. Ledeboer c.s
From:
13/12/2013
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

Opposition

Appeals

Appeal Request Number:
000031
Appeal Filling Date:
21/07/2014
Requestor For Appeal Name:
ARIAD PHARMACEUTICALS, INC.
Appeal Reason:
Unknown
Appeal Type:
Internal Appeal
Appeal Status:
Completed
Appeal Decision:
Positive
Appeal Decision Issued Date:
11/02/2016
Appeal Decision Summary:

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
12/25
Publication date:
19/03/2025
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
VB1
Journal edition number:
07/16
Publication date:
17/02/2016
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

3

Bulletin Heading:
VB1
Journal edition number:
2014/31
Publication date:
30/07/2014
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

4

Bulletin Heading:
SPC
Journal edition number:
2014/25
Publication date:
18/06/2014
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

5

Bulletin Heading:
SPC
Journal edition number:
2013/52
Publication date:
25/12/2013
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC202500411A
Date Registered:
05/03/2025
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. B.Ch. Ledeboer c.s
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Merge
Deed Number:
RC202500411B
Date Registered:
05/03/2025
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. B.Ch. Ledeboer c.s
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Takeda Pharmaceuticals U.S.A., Inc.
Address:
500 Kendall Street, 02142, Cambridge, MA, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/12/2026
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
11/02/2016 Restoration Restoration 2 PDF /1/3/6/0/0/0400300631/docs/300631_4_beschikking c 300631.pdf
11/02/2016 SPC Documents Certificate SPC 1 PDF /1/3/6/0/0/0400300631/docs/300631_17_supplprotectioncertificate20201016104549576.pdf
26/01/2016 Appeal Mail appeal procedure 3 PDF /1/3/6/0/0/0400300631/docs/300631_15_appeal20201019024457773.pdf
30/12/2015 Appeal Mail appeal procedure 1 PDF /1/3/6/0/0/0400300631/docs/300631_13_appeal20201019024304306.pdf
29/07/2014 Outgoing Correspondence Outgoing Letter 1 PDF /1/3/6/0/0/0400300631/docs/300631_3_outgoingcorrespondence20140729.pdf
18/07/2014 Appeal Subsequently filed documents appeal procedure 21 PDF /1/3/6/0/0/0400300631/docs/300631_0_appeal20140718.pdf
18/07/2014 Appeal Subsequently filed documents appeal procedure 7 PDF /1/3/6/0/0/0400300631/docs/300631_6_appeal20140718.pdf
18/07/2014 Appeal Request appeal 5 PDF /1/3/6/0/0/0400300631/docs/300631_8_appeal20140718.pdf
18/07/2014 Appeal Subsequently filed documents appeal procedure 2 PDF /1/3/6/0/0/0400300631/docs/300631_9_appeal20140718.pdf
18/07/2014 Appeal Subsequently filed documents appeal procedure 1 PDF /1/3/6/0/0/0400300631/docs/300631_10_appeal20140718.pdf
18/07/2014 Appeal Subsequently filed documents appeal procedure 15 PDF /1/3/6/0/0/0400300631/docs/300631_21_appeal20140718.pdf
15/07/2014 Appeal Request appeal 51 PDF /1/3/6/0/0/0400300631/docs/300631_7_appeal20201019023315687.pdf
03/06/2014 SPC Documents Certificate SPC 1 PDF /1/3/6/0/0/0400300631/docs/300631_14_supplprotectioncertificate20201016100213658.pdf
03/06/2014 Outgoing Correspondence Outgoing Letter 1 PDF /1/3/6/0/0/0400300631/docs/300631_19_outgoingcorrespondence20140603.pdf
26/05/2014 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /1/3/6/0/0/0400300631/docs/300631_16_incomingcorrespondencepaper20210315013622977.pdf
03/04/2014 Outgoing Correspondence Outgoing Letter 2 PDF /1/3/6/0/0/0400300631/docs/300631_20_outgoingcorrespondence20140403.pdf
17/12/2013 Outgoing Correspondence Outgoing Letter 1 PDF /1/3/6/0/0/0400300631/docs/300631_2_outgoingcorrespondence20131217.pdf
16/12/2013 SPC Documents Marketing Authorization SPC 3 PDF /1/3/6/0/0/0400300631/docs/300631_1_supplprotectioncertificate20201016095416348.pdf
16/12/2013 SPC Documents Annex SPC 14 PDF /1/3/6/0/0/0400300631/docs/300631_5_supplprotectioncertificate20201016095222576.pdf
16/12/2013 SPC Documents Accompanying letter SPC 1 PDF /1/3/6/0/0/0400300631/docs/300631_11_supplprotectioncertificate20201016095611141.pdf
16/12/2013 SPC Documents Annex SPC 3 PDF /1/3/6/0/0/0400300631/docs/300631_12_supplprotectioncertificate20201016095222529.pdf
16/12/2013 SPC Documents Summary of the characteristics of the product 35 PDF /1/3/6/0/0/0400300631/docs/300631_18_supplprotectioncertificate20201016095222460.pdf
16/12/2013 Application Form First filed application form 3 PDF /1/3/6/0/0/0400300631/docs/300631_22_applicationform20131216.pdf